{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:08:29Z","timestamp":1786118909846,"version":"build-2736575974"},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1097\/mph.0b013e318180bbc9","type":"journal-article","created":{"date-parts":[[2008,9,30]],"date-time":"2008-09-30T03:12:01Z","timestamp":1222744321000},"page":"749-753","source":"Crossref","is-referenced-by-count":9,"title":["Late Side Effects of High-dose Steroid Therapy on Skeletal System in Children With Idiopathic Thrombocytopenic Purpura"],"prefix":"10.1097","volume":"30","author":[{"given":"Z\u00fchal Keskin","family":"Yldrm","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa","family":"B\u00fcy\u00fckavc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suat","family":"Eren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zerrin","family":"Orbak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cahit","family":"Karakelleo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210227","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1046\/j.1365-2141.2003.04131.x","article-title":"Guidelines for the investigation and management of idiopathic thrombocytopenic purpura in adults, children and in pregnancy","volume":"120","year":"2003","journal-title":"Br J Haematol"},{"key":"R2-8-20210227","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1016\/S0140-6736(96)12118-8","article-title":"Autoimmune (idiopathic) thrombocytopenic purpura","volume":"349","author":"Karpatkin","year":"1997","journal-title":"Lancet"},{"key":"R3-8-20210227","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1055\/s-2004-815628","article-title":"Childhood acute immune thrombocytopenic purpura: 20 years later","volume":"29","author":"Blanchette","year":"2003","journal-title":"Semin Thromb Hemost"},{"key":"R4-8-20210227","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1080\/08880010252899370","article-title":"Clinical course of children with immune thrombocytopenic purpura treated with intravenous immunoglobulin G or megadose methylprednisolone or observed without therapy","volume":"19","author":"Duru","year":"2002","journal-title":"Pediatr Hematol Oncol"},{"key":"R5-8-20210227","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0022-3476(05)82024-4","article-title":"Acute immune thrombocytopenic purpura: a comparative study of very high oral doses of methylprednisolone and intravenously administered immune globulin","volume":"125","author":"Albayrak","year":"1994","journal-title":"J Pediatr"},{"key":"R6-8-20210227","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.bone.2004.04.005","article-title":"Reduced bone mineral density in childhood chronic idiopathic thrombocytopenic purpura treated with high-dose methylprednisolone","volume":"35","author":"Dilber","year":"2004","journal-title":"Bone"},{"key":"R7-8-20210227","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1016\/S0272-6386(03)00348-2","article-title":"Are children with idiopathic nephrotic syndrome at risk for metabolic bone disease?","volume":"41","author":"Gulati","year":"2003","journal-title":"Am J Kidney Dis"},{"key":"R8-8-20210227","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1365-2710.2000.00284.x","article-title":"Is enough attention being given to the adverse effects of corticosteroid therapy?","volume":"25","author":"Hougardy","year":"2000","journal-title":"J Clin Pharm Ther"},{"key":"R9-8-20210227","first-page":"760","article-title":"Nelson Textbook of Pediatrics. 16th ed","author":"Liu","year":"2004"},{"key":"R10-8-20210227","first-page":"77","article-title":"Glucocorticoid-induced osteoporosis","volume":"60","author":"Compston","year":"2003","journal-title":"Horm Res"},{"key":"R11-8-20210227","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1007\/s002230010039","article-title":"Acute alteration in bone mineral density and biochemical markers for bone metabolism in nephrotic patients receiving high-dose glucocorticoid and one-cycle etidronate therapy","volume":"66","author":"Fujita","year":"2000","journal-title":"Calcif Tissue Int"},{"key":"R12-8-20210227","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1007\/s00223-002-2099-x","article-title":"Biochemical markers of bone metabolism in infants and children under intravenous corticosteroid therapy","volume":"73","author":"Siomou","year":"2003","journal-title":"Calcif Tissue Int"},{"key":"R13-8-20210227","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1002\/1529-0131(200107)44:7<1496::AID-ART271>3.0.CO;2-5","article-title":"Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update","volume":"44","year":"2001","journal-title":"Arthritis Rheum"},{"key":"R14-8-20210227","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0889-8529(05)70007-4","article-title":"Biochemical markers of bone turnover. Applications for osteoporosis","volume":"27","author":"Garnero","year":"1998","journal-title":"Endocrinol Metab Clin North America"},{"key":"R15-8-20210227","first-page":"437","article-title":"Pediatric Hematology. 2nd ed","author":"Impach","year":"2000"},{"key":"R16-8-20210227","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1530\/eje.0.1370209","article-title":"Glucocorticoid osteoporosis-mechanisms and management","volume":"137","author":"Reid","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"R17-8-20210227","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1590\/S0004-27302007000800028","article-title":"Glucocorticoid-induced osteoporosis: clinical and therapeutic aspects","volume":"51","author":"Mazziotti","year":"2007","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"R18-8-20210227","first-page":"292","article-title":"Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 4th ed","author":"Lukert","year":"1999"},{"key":"R19-8-20210227","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10067-004-0989-1","article-title":"Bone mineral density in patients with early rheumatoid arthritis treated with corticosteroids","volume":"24","author":"Habib","year":"2005","journal-title":"Clin Rheumatol"},{"key":"R20-8-20210227","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1378\/chest.120.5.1468","article-title":"Effects of inhaled corticosteroid and short courses of oral corticosteroids on bone mineral density in asthmatic patients: a 4-year longitudinal study","volume":"120","author":"Matsumoto","year":"2001","journal-title":"Chest"},{"key":"R21-8-20210227","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/(SICI)1096-911X(199901)32:1<11::AID-MPO4>3.0.CO;2-F","article-title":"Osteonecrosis during the treatment childhood acute lymphoblastic leukemia: a prospective MRI study","volume":"32","author":"Ojala","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"R22-8-20210227","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1002\/1097-0142(19900415)65:8<1717::AID-CNCR2820650809>3.0.CO;2-B","article-title":"Osteonecrosis in pediatric patients with acute lymphoblastic leukemia","volume":"65","author":"Murphy","year":"1990","journal-title":"Cancer"},{"key":"R23-8-20210227","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1302\/0301-620X.75B3.8496201","article-title":"Early detection of avascular necrosis of the femoral head by MRI","volume":"75","author":"Fordyce","year":"1993","journal-title":"Bone Joint Surg Br"},{"key":"R24-8-20210227","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/S0140-6736(87)92870-4","article-title":"Across-study evaluation of association between steroid dose and bolus steroids and avascular necrosis of bone","volume":"18","author":"Felsen","year":"1987","journal-title":"Lancet"},{"key":"R25-8-20210227","first-page":"525","article-title":"Osteonecrosis diagnosed on MR images of the knee. Relationship to reduced bone mineral density determined by high resolution peripheral quantitative CT","volume":"44","author":"Zanetti","year":"2003","journal-title":"Acta Radiol"},{"key":"R26-8-20210227","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/sj.bmt.1704360","article-title":"Bone mineral density and osteonecrosis in survivors of childhood allogeneic bone marrow transplantation","volume":"33","author":"Kaste","year":"2004","journal-title":"Bone Marrow Transplant"}],"container-title":["Journal of Pediatric Hematology\/Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MPH.0b013e318180bbc9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:05:09Z","timestamp":1786035909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00043426-200810000-00008"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":26,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mph.0b013e318180bbc9","relation":{},"ISSN":["1077-4114"],"issn-type":[{"value":"1077-4114","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}